Phase 2a Study of HPG1860 in Subjects With NASH

Clinical trial NCT05338034 · COMPLETED

Trial details

NCT number: NCT05338034
Sponsor: Hepagene (Shanghai) Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis

Start date: 2021-11-22
Primary completion: 2023-02-28
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.